Cargando…
Lung Cancer Therapy Targeting Histone Methylation: Opportunities and Challenges
Lung cancer is one of the most common malignancies. In spite of the progress made in past decades, further studies to improve current therapy for lung cancer are required. Dynamically controlled by methyltransferases and demethylases, methylation of lysine and arginine residues on histone proteins r...
Autores principales: | Chen, Yuchen, Liu, Xinran, Li, Yangkai, Quan, Chuntao, Zheng, Ling, Huang, Kun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Network of Computational and Structural Biotechnology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039709/ https://www.ncbi.nlm.nih.gov/pubmed/30002791 http://dx.doi.org/10.1016/j.csbj.2018.06.001 |
Ejemplares similares
-
Targeting histone methylation for colorectal cancer
por: Huang, Tao, et al.
Publicado: (2016) -
Inhibition of kinesin family member 20B sensitizes hepatocellular carcinoma cell to microtubule‐targeting agents by blocking cytokinesis
por: Liu, Xinran, et al.
Publicado: (2018) -
Reducing protein regulator of cytokinesis 1 as a prospective therapy for hepatocellular carcinoma
por: Liu, Xinran, et al.
Publicado: (2018) -
Targeting histone deacetylases for cancer therapy: Trends and challenges
por: Liang, Tao, et al.
Publicado: (2023) -
Targeting Histone Deacetylases: Opportunities for Cancer Treatment and Chemoprevention
por: Ruzic, Dusan, et al.
Publicado: (2022)